4Cheng AL.Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma.Blood 1996；87:1202.
5Kumagai K, Takagi T,Nakamura S, Sawada U,Kura Y,Kodama Ft Shimano S, Kudoh I, Nakamura H, Sawada K,Ohnoshi T.Hepatitis B virus carriers in the treatment of malignant lymphoma:an epidemiological study in Japan.Ann Oncol 1997:8(Suvvl 1):107-109.
6Faggiolli P, De Paschale M, Tocci A, Luoni M, Fava S, De Pali A, Tosi A, Cassi E. Acute hepatic toxicity during cyclic chemotherapy in non-Hodgkin's lymphoma. Hematologica 1997; 82: 38-42.
7Perrillo RP. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001; 120:1009-1022.
8Cheng AL, Hsiung CA, Su IJ, Chen PJ, Chang MC, Tsao CJ,Kao WY, Uen WC, Hsu CH, Tien HF, Chao TY, Chen LT,Wang-Peng J. Lymphoma Committee of Taiwan Cooperative Oncology Group. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology 2003;37:1320-1328.
9Kao JH,Chen PJ,Lai MY,Chen DS.Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B.Gastroenterology 2000；118:554-559.
10Triger DR,Wright R.Hyperglobulinaemia in liver disease.Lancet 1973；1:1494-1496.
